January 31, 2017
Actavis, Lannett and another manufacturer of generic ursodiol are the latest companies accused of using trade group meetings as opportunities to conspire to improperly raise generic drug prices to "dizzying" levels, an employee benefit fund said in a proposed class action filed Monday in New Jersey federal court.